Novo Integrated Sciences Stock Working Capital
Novo Integrated Sciences fundamentals help investors to digest information that contributes to Novo Integrated's financial success or failures. It also enables traders to predict the movement of Novo Pink Sheet. The fundamental analysis module provides a way to measure Novo Integrated's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Novo Integrated pink sheet.
Novo |
Novo Integrated Sciences Company Working Capital Analysis
Novo Integrated's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Novo Integrated Working Capital | (3.52 M) |
Most of Novo Integrated's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Novo Integrated Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
CompetitionBased on the company's disclosures, Novo Integrated Sciences has a Working Capital of (3.52 Million). This is 100.83% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The working capital for all United States stocks is 100.24% higher than that of the company.
Novo Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Novo Integrated's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Novo Integrated could also be used in its relative valuation, which is a method of valuing Novo Integrated by comparing valuation metrics of similar companies.Novo Integrated is currently under evaluation in working capital category among its peers.
Novo Fundamentals
| Return On Equity | -1.35 | ||||
| Return On Asset | -0.18 | ||||
| Profit Margin | (1.80) % | ||||
| Operating Margin | (0.80) % | ||||
| Current Valuation | 5.8 M | ||||
| Shares Outstanding | 19.05 M | ||||
| Shares Owned By Insiders | 6.82 % | ||||
| Shares Owned By Institutions | 5.77 % | ||||
| Number Of Shares Shorted | 274.86 K | ||||
| Price To Book | 0.29 X | ||||
| Price To Sales | 0.21 X | ||||
| Revenue | 12.57 M | ||||
| Gross Profit | 3.82 M | ||||
| EBITDA | (5.63 M) | ||||
| Net Income | (13.27 M) | ||||
| Cash And Equivalents | 12.68 M | ||||
| Cash Per Share | 0.41 X | ||||
| Total Debt | 4.47 M | ||||
| Debt To Equity | 0.48 % | ||||
| Current Ratio | 1.58 X | ||||
| Book Value Per Share | 0.52 X | ||||
| Cash Flow From Operations | (2.24 M) | ||||
| Short Ratio | 1.13 X | ||||
| Earnings Per Share | (0.41) X | ||||
| Number Of Employees | 127 | ||||
| Beta | -0.69 | ||||
| Market Capitalization | 2.84 M | ||||
| Total Asset | 35.56 M | ||||
| Retained Earnings | (67.03 M) | ||||
| Working Capital | (3.52 M) | ||||
| Net Asset | 35.56 M |
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Novo Pink Sheet
If you are still planning to invest in Novo Integrated Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Novo Integrated's history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |